抗人 SCYL3 抗体对
01AB01338
SCY1 like pseudokinase 3 (SCYL3), also known as PACE-1, is a member of the SCYL protein family characterized by an inactive kinase domain, central HEAT repeats, and a disorganized C-terminal segment. Unlike conventional kinases, SCYL3's pseudokinase domain lacks catalytic activity but may play roles in protein trafficking and signaling pathway assembly. Unique to SCYL3 is a myristoylation consensus sequence at the N-terminus, which facilitates membrane association. SCYL3 interacts with ezrin through its C-terminal domain and has been implicated in intracellular processes such as clathrin-mediated endocytosis and neuronal function. Clinically, SCYL3 is overexpressed in hepatocellular carcinoma (HCC), where it promotes tumor progression by regulating ROCK2 activity. Patients with high SCYL3 expression exhibit reduced survival rates. Additionally, SCYL3 plays overlapping roles with SCYL1 in motor neuron viability, and its disruption accelerates neurodegenerative conditions resembling amyotrophic lateral sclerosis (ALS).
| 规格 | 起售价 |
|---|---|
| 登录后可查看 | |
技术参数
- 靶点基因名
- SCYL3
- 基因别名
- PACE1
- 蛋白别名
- SCY1 like pseudokinase 3; SCYL3
- UniProt
- Q8IZE3
- 物种
- Human
产品详情
- 靶点名称
- SCYL3
- 蛋白名称
- SCY1 like pseudokinase 3
- 蛋白别名
- Protein-associating with the carboxyl-terminal domain of ezrin; Ezrin-binding protein PACE-1; SCY1-like protein 3
- 靶点基因名
- SCYL3
- 基因别名
- PACE1
- UniProt
- Q8IZE3
- 来源物种
- Homo sapiens (Human)
- 物种反应性
- Human
背景介绍
SCY1 like pseudokinase 3 (SCYL3), also known as PACE-1, is a member of the SCYL protein family characterized by an inactive kinase domain, central HEAT repeats, and a disorganized C-terminal segment. Unlike conventional kinases, SCYL3's pseudokinase domain lacks catalytic activity but may play roles in protein trafficking and signaling pathway assembly. Unique to SCYL3 is a myristoylation consensus sequence at the N-terminus, which facilitates membrane association. SCYL3 interacts with ezrin through its C-terminal domain and has been implicated in intracellular processes such as clathrin-mediated endocytosis and neuronal function. Clinically, SCYL3 is overexpressed in hepatocellular carcinoma (HCC), where it promotes tumor progression by regulating ROCK2 activity. Patients with high SCYL3 expression exhibit reduced survival rates. Additionally, SCYL3 plays overlapping roles with SCYL1 in motor neuron viability, and its disruption accelerates neurodegenerative conditions resembling amyotrophic lateral sclerosis (ALS).